Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DBE. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101747206A reveals a high-yield reductive amination route for N,N-dibenzyl-ethylenediamin diacetate, offering significant cost reduction in API manufacturing and superior purity profiles.
Advanced catalytic hydrogenation patent CN106748813B enables high-selectivity DBE production. Discover cost-effective supply chain solutions for pharmaceutical intermediates.
Novel 3-step synthesis of FR20 inhibitor avoids toxic reagents. High atom economy and scalable process for pharmaceutical intermediates.
Patent CN111943930A reveals a mild copper-catalyzed route for Lasmiditan. This process eliminates noble metals, offering significant cost reduction and scalable manufacturing for API intermediates.
Novel copper-catalyzed Goldberg reaction method reduces temperature and time for phenylamide production, offering cost-effective supply chain solutions.